Çalıbaşı Koçal, G. Et Al. 2012. The relationship between Kras-Braf mutations and resistance to anti-EGFR therapies in colorectal cancer. ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs , (İstanbul, Turkey), 1.

Çalıbaşı Koçal, G., Amirfallah, A., Başbınar, Y., Sarıoğlu, S., Sağol, Ö., Öztop, İ., ... Ellidokuz, H.(2012). The relationship between Kras-Braf mutations and resistance to anti-EGFR therapies in colorectal cancer . ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs (pp.1). İstanbul, Turkey

Çalıbaşı Koçal, GİZEM Et Al. "The relationship between Kras-Braf mutations and resistance to anti-EGFR therapies in colorectal cancer," ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs, İstanbul, Turkey, 2012

Çalıbaşı Koçal, GİZEM Ç. Et Al. "The relationship between Kras-Braf mutations and resistance to anti-EGFR therapies in colorectal cancer." ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs , İstanbul, Turkey, pp.1, 2012

Çalıbaşı Koçal, G. Et Al. (2012) . "The relationship between Kras-Braf mutations and resistance to anti-EGFR therapies in colorectal cancer." ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs , İstanbul, Turkey, p.1.

@conferencepaper{conferencepaper, author={GİZEM ÇALIBAŞI KOÇAL Et Al. }, title={The relationship between Kras-Braf mutations and resistance to anti-EGFR therapies in colorectal cancer}, congress name={ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs}, city={İstanbul}, country={Turkey}, year={2012}, pages={1} }